- Home
- BB vs CNTA Comparison
BB vs CNTA Comparison
Compare BB & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- CNTA
- Stock Information
- Founded
- BB 1984
- CNTA 2020
- Country
- BB Canada
- CNTA United Kingdom
- Employees
- BB N/A
- CNTA N/A
- Industry
- BB
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BB
- CNTA Health Care
- Exchange
- BB Nasdaq
- CNTA Nasdaq
- Market Cap
- BB 2.2B
- CNTA 2.3B
- IPO Year
- BB 1997
- CNTA 2021
- Fundamental
- Price
- BB $4.01
- CNTA $21.85
- Analyst Decision
- BB Buy
- CNTA Strong Buy
- Analyst Count
- BB 6
- CNTA 11
- Target Price
- BB $4.64
- CNTA $30.60
- AVG Volume (30 Days)
- BB 5.9M
- CNTA 1.5M
- Earning Date
- BB 09-25-2025
- CNTA 11-11-2025
- Dividend Yield
- BB N/A
- CNTA N/A
- EPS Growth
- BB N/A
- CNTA N/A
- EPS
- BB N/A
- CNTA N/A
- Revenue
- BB $533,200,000.00
- CNTA $15,000,000.00
- Revenue This Year
- BB $2.17
- CNTA N/A
- Revenue Next Year
- BB $7.03
- CNTA N/A
- P/E Ratio
- BB N/A
- CNTA N/A
- Revenue Growth
- BB 4.65
- CNTA 118.88
- 52 Week Low
- BB $2.24
- CNTA $9.60
- 52 Week High
- BB $6.24
- CNTA $23.24
- Technical
- Relative Strength Index (RSI)
- BB 62.79
- CNTA 68.27
- Support Level
- BB $3.92
- CNTA $20.94
- Resistance Level
- BB $4.05
- CNTA $23.24
- Average True Range (ATR)
- BB 0.11
- CNTA 1.33
- MACD
- BB 0.03
- CNTA 0.41
- Stochastic Oscillator
- BB 84.21
- CNTA 83.11
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.